Abstract:Electrophysiologic disturbances due to neurodegenerative disorders such as Alzheimer's disease and Lewy Body disease are detectable by scalp EEG and can serve as a functional measure of disease severity. Traditional quantitative methods of EEG analysis often require an a-priori selection of clinically meaningful EEG features and are susceptible to bias, limiting the clinical utility of routine EEGs in the diagnosis and management of neurodegenerative disorders. We present a data-driven tensor decomposition approach to extract the top 6 spectral and spatial features representing commonly known sources of EEG activity during eyes-closed wakefulness. As part of their neurologic evaluation at Mayo Clinic, 11 001 patients underwent 12 176 routine, standard 10-20 scalp EEG studies. From these raw EEGs, we developed an algorithm based on posterior alpha activity and eye movement to automatically select awake-eyes-closed epochs and estimated average spectral power density (SPD) between 1 and 45 Hz for each channel. We then created a three-dimensional (3D) tensor (record × channel × frequency) and applied a canonical polyadic decomposition to extract the top six factors. We further identified an independent cohort of patients meeting consensus criteria for mild cognitive impairment (30) or dementia (39) due to Alzheimer's disease and dementia with Lewy Bodies (31) and similarly aged cognitively normal controls (36). We evaluated the ability of the six factors in differentiating these subgroups using a Naïve Bayes classification approach and assessed for linear associations between factor loadings and Kokmen short test of mental status scores, fluorodeoxyglucose (FDG) PET uptake ratios and CSF Alzheimer's Disease biomarker measures. Factors represented biologically meaningful brain activities including posterior alpha rhythm, anterior delta/theta rhythms and centroparietal beta, which correlated with patient age and EEG dysrhythmia grade. These factors were also able to distinguish patients from controls with a moderate to high degree of accuracy (Area Under the Curve (AUC) 0.59-0.91) and Alzheimer's disease dementia from dementia with Lewy Bodies (AUC 0.61). Furthermore, relevant EEG features correlated with cognitive test performance, PET metabolism and CSF AB42 measures in the Alzheimer's subgroup. This study demonstrates that data-driven approaches can extract biologically meaningful features from population-level clinical EEGs without artefact rejection or a-priori selection of channels or frequency bands. With continued development, such data-driven methods may improve the clinical utility of EEG in memory care by assisting in early identification of mild cognitive impairment and differentiating between different neurodegenerative causes of cognitive impairment.

Accurate deep-learning model to differentiate dementia severity and diagnosis using a portable electroencephalography device

Precise Discrimination for Multiple Etiologies of Dementia Cases Based on Deep Learning with Electroencephalography

Utilizing portable electroencephalography to screen for pathology of Alzheimer's disease: a methodological advancement in diagnosis of neurodegenerative diseases

Predictive Diagnostic Approach to Dementia and Dementia Subtypes Using Wireless and Mobile Electroencephalography: A Pilot Study

Develop a Diagnostic Tool for Dementia Using Machine Learning and Non-Imaging Features

Assisting Schizophrenia Diagnosis Using Clinical Electroencephalography and Interpretable Graph Neural Networks: a Real-World and Cross-Site Study

Screening of Mild Cognitive Impairment Subtypes Through the Training of 1D Convolutional Neural Network with QEEG Features

Fully Automated Discrimination of Alzheimer's Disease Using Resting-State Electroencephalography Signals.

EEG-Based Classification Between Individuals with Mild Cognitive Impairment and Healthy Controls Using Conformal Kernel-Based Fuzzy Support Vector Machine

Neurotechnology and AI Approach for Early Dementia Onset Biomarker from EEG in Emotional Stimulus Evaluation Task

Neural Biomarker Diagnosis and Prediction to Mild Cognitive Impairment and Alzheimer’s Disease Using EEG Technology

Differentiation of Subjective Cognitive Decline, Mild Cognitive Impairment, and Dementia Using qEEG/ERP-Based Cognitive Testing and Volumetric MRI in an Outpatient Specialty Memory Clinic

Mild Cognitive Impairment detection based on EEG and HRV data

Recent deep learning models for dementia as point-of-care testing: Potential for early detection

Using Dual Neural Network Architecture to Detect the Risk of Dementia with Community Health Data: Algorithm Development and Validation Study

Deep Learning-based Classification of Dementia using Image Representation of Subcortical Signals

An attention-based deep learning approach for the classification of subjective cognitive decline and mild cognitive impairment using resting-state EEG

Data-driven retrieval of population-level EEG features and their role in neurodegenerative diseases

Deep Insights into MCI Diagnosis: A Comparative Deep Learning Analysis of EEG Time Series

EEG-SSM: Leveraging State-Space Model for Dementia Detection

Deep learning techniques for automated Alzheimer's and mild cognitive impairment disease using EEG signals: A comprehensive review of the last decade (2013 - 2024)